Long-Term Levels of LDL-C and Cognitive Function: The CARDIA Study
- PMID: 33563358
- PMCID: PMC8353005
- DOI: 10.1017/S1355617721000059
Long-Term Levels of LDL-C and Cognitive Function: The CARDIA Study
Abstract
Objectives: It is uncertain if long-term levels of low-density lipoprotein-cholesterol (LDL-C) affect cognition in middle age. We examined the association of LDL-C levels over 25 years with cognitive function in a prospective cohort of black and white US adults.
Methods: Lipids were measured at baseline (1985-1986; age: 18-30 years) and at serial examinations conducted over 25 years. Time-averaged cumulative LDL-C was calculated using the area under the curve for 3,328 participants with ≥3 LDL-C measurements and a cognitive function assessment. Cognitive function was assessed at the Year 25 examination with the Digit Symbol Substitution Test [DSST], Rey Auditory Visual Learning Test [RAVLT], and Stroop Test. A brain magnetic resonance imaging (MRI) sub-study (N = 707) was also completed at Year 25 to assess abnormal white matter tissue volume (AWMV) and gray matter cerebral blood flow volume (GM-CBFV) as secondary outcomes.
Results: There were 15.6%, 32.9%, 28.9%, and 22.6% participants with time-averaged cumulative LDL-C <100 mg/dL, 101-129 mg/dL, 130-159 mg/dL, and ≥160 mg/dL, respectively. Standardized differences in all cognitive function test scores ranged from 0.16 SD lower to 0.09 SD higher across time-averaged LDL-C categories in comparison to those with LDL-C < 100 mg/dL. After covariate adjustment, participants with higher versus lower time-averaged LDL-C had a lower RAVLT score (p-trend = 0.02) but no differences were present for DSST, Stroop Test, AWMV, or GM-CBFV.
Conclusion: Cumulative LDL-C was associated with small differences in memory, as assessed by RAVLT scores, but not other cognitive or brain MRI measures over 25 years of follow-up.
Keywords: Cholesterol; Cognition; Cohort studies; LDL; Lipids.
Conflict of interest statement
Conflict of Interest Disclosures: MM and LC report no disclosures. CEL receives research support from grant HHSN26820130026C. PM receives research support from Amgen, Inc. SS and LJL report no disclosures. KLM, AR, and HK are employed by Amgen, Inc. RSR receives research grant support from Akcea, Amgen, Medicines Company and Sanofi; he receives honoraria from Akcea, Kowa, and Pfizer; he has ownership in MediMergent; he receives consultant fees from Akcea, Amgen, Regeneron, and Sanofi; he receives other support from UpToDate. APC receives research support from Amgen, Inc.
References
-
- Alfred T, Ben-Shlomo Y, Cooper R, Hardy R, Cooper C, Deary IJ, … HALCyon Study Team. (2014). Associations between APOE and low-density lipoprotein cholesterol genotypes and cognitive and physical capability: the HALCyon programme. Age (Dordr), 36(4), 9673. doi:10.1007/s11357-014-9673-9 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical